Literature DB >> 20073550

Hypothesizing an ancient Greek origin of the GJB2 35delG mutation: can science meet history?

Haris Kokotas1, Maria Grigoriadou, Manuela Villamar, Aglaia Giannoulia-Karantana, Ignacio del Castillo, Michael B Petersen.   

Abstract

One specific mutation of the GJB2 gene that encodes the connexin 26 protein, the 35delG mutation, has become a major interest among scientists who focus on the genetics of nonsyndromic hearing loss. The mutation accounts for the majority of GJB2 mutations detected in Caucasian populations and represents one of the most frequent disease mutations identified so far. The debate was so far between the arguments whether or not the 35delG mutation constitutes a mutational hot-spot or a founder effect; however, it was recently clarified that the latter seems the most likely. In an attempt to explore the origin and propagation of the 35delG mutation, several groups have reported the prevalence of the mutation and the carrier rates in different populations worldwide. It is now certain that the theory of a common founder prevails and that the highest carrier frequencies of the 35delG mutation are observed in southern European populations, giving rise to a discussion regarding the origin of the 35delG mutation. In this study, we discuss data previously published by our and other groups and also compare the haplotype distribution of the mutation in southern Europe, trying to understand the pathways of science and history and the conflict between them.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20073550     DOI: 10.1089/gtmb.2009.0146

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

1.  Haplotype Diversity and Reconstruction of Ancestral Haplotype Associated with the c.35delG Mutation in the GJB2 (Cx26) Gene among the Volgo-Ural Populations of Russia.

Authors:  L U Dzhemileva; O L Posukh; N A Barashkov; S A Fedorova; F M Teryutin; V L Akhmetova; I M Khidiyatova; R I Khusainova; S L Lobov; E K Khusnutdinova
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

2.  Did the GJB2 35delG mutation originate in Iran?

Authors:  Vahideh Norouzi; Hiva Azizi; Zohreh Fattahi; Fatemehsadat Esteghamat; Niloofar Bazazzadegan; Carla Nishimura; Nooshin Nikzat; Khadijeh Jalalvand; Kimia Kahrizi; Richard J H Smith; Hossein Najmabadi
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

3.  Hearing impairment locus heterogeneity and identification of PLS1 as a new autosomal dominant gene in Hungarian Roma.

Authors:  Isabelle Schrauwen; Béla I Melegh; Imen Chakchouk; Anushree Acharya; Abdul Nasir; Alexis Poston; Diana M Cornejo-Sanchez; Zsolt Szabo; Tamás Karosi; Judit Bene; Béla Melegh; Suzanne M Leal
Journal:  Eur J Hum Genet       Date:  2019-03-14       Impact factor: 4.246

4.  High Rates of Three Common GJB2 Mutations c.516G>C, c.-23+1G>A, c.235delC in Deaf Patients from Southern Siberia Are Due to the Founder Effect.

Authors:  Marina V Zytsar; Marita S Bady-Khoo; Valeriia Yu Danilchenko; Ekaterina A Maslova; Nikolay A Barashkov; Igor V Morozov; Alexander A Bondar; Olga L Posukh
Journal:  Genes (Basel)       Date:  2020-07-21       Impact factor: 4.096

5.  Analysis of GJB2 Gene Mutations in 1330 Deafness Cases of Major Ethnic Groups in Northwest China.

Authors:  Panpan Bian; Baicheng Xu; Xiaoyun Zhao; YiMing Zhu; Chi Chen; XingJian Chen; Xiaowen Liu; Yanli Wang; Yufen Guo
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

6.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

7.  Updated carrier rates for c.35delG (GJB2) associated with hearing loss in Russia and common c.35delG haplotypes in Siberia.

Authors:  Marina V Zytsar; Nikolay A Barashkov; Marita S Bady-Khoo; Olga A Shubina-Olejnik; Nina G Danilenko; Alexander A Bondar; Igor V Morozov; Aisen V Solovyev; Valeriia Yu Danilchenko; Vladimir N Maximov; Olga L Posukh
Journal:  BMC Med Genet       Date:  2018-08-07       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.